NewsRx

Search our medical news database

Cancer Weekly

Susan Hasty, Publisher

Table of Contents . . . April 3rd, 1995

Non-Subscriber - Summaries Only

Related Areas: Other Issues in Cancer Weekly | Other Publications

Liposomes - Anti-p185HER2 Immunoliposomes Developed for Cancer Therapy

Melanoma - Hyperthermia Adjuvant to Radiotherapy Improves Prognosis

NSCLC - Tumor Suppressor Protein Shows Promise as Efficient Cancer Therapeutic

Therapy/Genital Warts - Backburner Placement Irritates HPV Treatment Manufacturers

Gene Therapy - Vectors - "Retroviral Transfer of the Human Cytosolic Aldehyde Dehydrogenase Gene as a Means to Generate Cellular Cyclophosphamide Resistance."

Opportunistic Infection - "Kaposi's Sarcoma in HIV Infected Women: About Four Cases."

Therapy - "Platelet Function after Combination Chemotherapy and Treatment with Recombinant Human Granulocyte-Colony-Stimulating Factor (rhG-CSF)."

Therapy - "Platelet Function in Patients with Advanced Malignancies Treated with Subcutaneous Recombinant Human Interleukin-1(beta) (IL-1 LEFTCURLYBRACK

Transplantation - Bone Marrow - "Autologous and Allogeneic Bone Marrow Transplantation for B-Cell CLL: Balance Between Toxicity and Efficacy."

Cancer/Gene Therapy - IL-12/IL-2 Combination - "Administration of Systemic or Local Interleukin-2 Enhances the Anti-Tumor Effects of interleukin-12 gene therapy."

Cancer/Gene Therapy - Liposome-Plasmid Complexes - "Inhibition of Human Ovarian Carcinoma Cell Proliferation by Liposome-Plasmid DNA Complex."

Cancer/Gene Therapy - cDNA Library Transfer - "Retroviral Transduction and Oncogenic Selection of a cDNA Encoding Dbs, a Homolog of the Dbl Guanine Nucleotide Exchange Factor."

Drug Resistance - Cellular Ascorbate Levels - "Ascorbic Acid and Cell Survival of Adriamycin Resistant and Sensitive MCF-7 Breast Tumor Cells."

Drug Resistance - N-myc Involvement - "Association Between Gene Alteration and Drug Sensitivity in Human Lung Carcinoma Cell Lines."

Therapy - Anti-CEA MAbs - "Breast Tumor Xenograft Targeting and Therapy Studies Using Radiolabeled Chimeric Anti-CEA Monoclonal Antibody T84.66."

Therapy - Modified Citrus Pectin - "Inhibition of Spontaneous Metastasis in a Rat Prostate Cancer Model by Oral Administration of Modified Citrus Pectin."

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook